Todd C. Brady - 05 May 2021 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Todd C. Brady
Issuer symbol
EVOK
Transactions as of
05 May 2021
Transactions value $
$0
Form type
4
Filing time
23 Jul 2021, 18:15:32 UTC
Previous filing
09 Mar 2023
Next filing
07 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +57.8K $0.00 57.8K 05 May 2021 Common Stock 57.8K $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Issuer through such vesting date.